Developing therapies for fibrocystic breasts and acne.
Industry: Health Care
First Day Return: -3.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 04/09/2015 |
Offer Price | $2.75 |
Price Range $2.75 - $3.25 | |
Offer Shares (mm) | 3.6 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 06/24/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Menlo Park, CA, United States |
Founded | 2010 |
Employees at IPO | 24 |
Website www.BioPharmX.com |